Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.
- NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_assertion description "[The data from the current study provide evidence that patients with HER2-positive breast cancer have a significantly higher incidence of CNS metastasis after treatment with trastuzumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.
- NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_assertion evidence source_evidence_literature NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.
- NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_assertion SIO_000772 21509760 NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.
- NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_assertion wasDerivedFrom befree-2016 NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.
- NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_assertion wasGeneratedBy ECO_0000203 NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.
- befree-2016 importedOn "2016-02-19" NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.